S10 Ep40: FDA Approval Insights: Imetelstat in Lower-Risk MDS and Transfusion-Dependent Anemia

from OncLive® On Air · host OncLive® On Air

Dr Sekeres discusses the significance of the FDA approval of imetelstat for patients with lower-risk MDS and transfusion-dependent anemia.

Episode metadata supplied by the publisher feed · Published Jul 1, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

S10 Ep40: FDA Approval Insights: Imetelstat in Lower-Risk MDS and Transfusion-Dependent Anemia

0:00 7:48

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on July 1, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!